NMRA neumoratx.com Kompaniya foydasi

NMRA (Neumora Therapeutics, Inc.) - kompaniyaning tovar belgisi

Neumora Therapeutics miya patologiyalari uchun innovatsion terapiyalarni ishlab chiqishga e'tibor qaratadi, bunda foyda ko'rsatkichi -0.21 ni tashkil etadi. Ushbu narxlar tendentsiyasi grafigi biznes rivojlanish dinamikasini tasdiqlaydi. Kompaniyaga keng ko'lamli investitsiyalar orqali jalb qilingan yetakchi neyrobiologiya ekspertlari jamoasi ko'maklashmoqda. Pilot dori seriyalarining ishlab chiqarilishi tashqi pudratchilarga topshirilgan bo'lib, bu texnik tanaffuslarsiz ishlab chiqarish sikllarining maksimal samaradorligini ta'minlaydi.

Sof daromad: Neumora Therapeutics Inc (NMRA) 21.02.2024 - 01.11.2026 uchun

Neumora Therapeutics, Inc. (NMRA) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
Birja narxi Neumora Corp|NMRA - Maqsadli narxlar grafigi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor kapitallashuvi Neumora Corp|NMRA - Korxona qiymati
- balans kapitallashuvi haqida ma'lumot:
Bitta aksiya hisobiga sof aktivlar qiymati Neumora Therapeutics|NMRA - Kompaniyaning sof aktivlari|Bozor kapitallashuvining balans qiymatiga nisbati neumoratx.com|NMRA - Kompaniyaning jami aktivlari
- qarz yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning xususiy kapitalga nisbati Neumora Therapeutics|NMRA - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli majburiyatlarning kapitalga nisbati Neumora|NMRA - Kompaniya qarzlari|Qarzning sof aktivlarga nisbati Neumora Corp|NMRA - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli qarzlari Neumora Therapeutics|Oraliq qoplash koeffitsiyenti neumoratx.com
- kompaniyaning daromadliligi va baholash multiplikatorlari ko'rsatkichlari:
NMRA - Sof daromad
Kompaniyaning asosiy tahlili:Neumora Corp (NMRA)
Neumora Therapeutics asosiy tovari

Himoyaviy portfel sof daromadning tiklanish darajini qat'iy nazorat qilishni talab qiladi. Ushbu ko'rsatkich balansning tiklanish sur'atini aniqlash uchun kunlik foydani joriy bozor kapitalizatsiyasi bilan solishtiradi. Neumora Therapeutics (NMRA) uchun ushbu hisob-kitob juda muhimdir, chunki foyda bevosita klinik sinovlarning muvaffaqiyati va tartibga soluvchi organlarning tasdiqlashiga bog'liq. Investorlar uchun rejalashtirilgan tadqiqotlar kengayishi va tizimli pasayishni bir-biridan ajratish muhimdir. Neumora Therapeutics (NMRA) ning foyda dinamikasi ushbu strategiyaning samaradorligini aniq tasdiqlaydi.

Toʻgʻridan-toʻgʻri raqobatchilar

Kompaniyaning sof daromadi Biogen Idec (BIIB)|Kompaniyaning sof foydasi Neurocrine Biosciences|Kompaniya foydasi RGC (regencellbioscience.com)|Sof foyda AXSM|ACAD - Kompaniyaning sof daromadi|Xenon Pharmaceuticals Inc - Sof daromad|Sof foyda Viking Therapeutics Corp VKTX|SUPN - Kompaniyaning sof foydasi|catalystpharma.com (CPRX) - Sof daromad|Denali Therapeutics Inc. (DNLI) - Kompaniyaning sof foydasi|Kompaniyaning sof daromadi Harmony Biosciences Inc (HRMY)|Kompaniyaning sof foydasi Biohaven Pharmaceutical|AMLX: Yakuniy foyda|Sof foyda TRVI|Sof foyda praxismedicines.com (PRAX)|Anavex Life Sciences Corp. - Sof daromad|Yakuniy foyda CBLL|PRTA: Sof daromad|Alector, Inc. - Soliqlar to‘langandan keyingi foyda|ANNX: Sof foyda|Omeros - Yakuniy foyda|NGNE (Neurogene) - Sof foyda|Kompaniyaning sof daromadi AC Immune S.A. ACIU|Kompaniyaning sof foydasi Voyager Pharma (VYGR)|SCLX (Scilex Holding Company, Inc.) - Yakuniy foyda|Sof foyda TVGN (Tevogen Bio Holdings)|Sof foyda Alpha Cognition Inc ACOG|CGTX - Kompaniyaning sof foydasi|Soliqdan keyingi foyda IKT|SAVA: Sof foyda|Kompaniyaning sof daromadi Assertio (ASRT)|Sof daromad COYA|Sof foyda VistaGen Therapeutics Inc|Sof daromad OVID (Ovid Therapeutics Inc.)|Soliqlar to‘langandan keyingi foyda ABOS|Sof foyda CRVO (CervoMed Inc)|Sof moliyaviy natija Alterity Therapeutics Ltd. (ATHE)|Clene Nanomedicine - Sof foyda|PepGen Inc. (PEPG) - Sof daromad|Jupiter Neurosciences Inc (JUNS) - Kompaniyaning sof foydasi|RLMD - Sof moliyaviy natija|Kompaniyaning sof foydasi Annovis Bio Corp|Kompaniya foydasi GRCE (Grace Tx)|Kompaniyaning sof foydasi Firefly Neuroscience, Inc (AIFF)|Sof daromad anewmeds.com KLTO|Kompaniyaning sof foydasi NeuroSense Therapeutics Ltd. NRSN|Yakuniy foyda RVPH|MetaVia, Inc. - Sof foyda|NRXS - Sof foyda|heliusmedical.com (HSDT) - Kompaniyaning sof foydasi|Kompaniya foydasi PASG|NEUP (Neuphoria Therapeutics, Inc.) - Sof foyda|Kompaniyaning sof daromadi Minerva Neurosciences Inc NERV|Sof daromad ATHA (Athira)|Sof foyda Addex (ADXN)|Kompaniyaning sof foydasi Alzamend Neuro ALZN|Yakuniy foyda CYCN|PTIX - Kompaniyaning sof foydasi|Kompaniyaning sof daromadi Pasithea Therapeutics|cortigent.com (CRGT) - Kompaniyaning sof foydasi|Kompaniya foydasi ATXI|BCLI (Brainstorm Cell) - Sof foyda|Kompaniyaning sof daromadi caratherapeutics.com CARA|Sof daromad CHRO (Chromocell Therapeutics Corp.)|Sof foyda eliemtx.com (ELYM)|Kompaniyaning sof foydasi Intra-Cellular Therapies, Inc. ITCI|LBPH - Sof daromad|MRNS - Kompaniyaning sof foydasi|Kompaniyaning sof daromadi nkgenbiotech.com|NeuroBo Pharmaceuticals, Inc. (NRBO) - Kompaniyaning sof foydasi|Sage Therapeutics Inc. - Yakuniy foyda|SNPX (Neurotrope) - Sof foyda|Sof foyda Trevena Inc|Sof daromad VIGL (Vigil Neuroscience)|WENA (Anew Medical Inc.) - Yakuniy foyda|Cerevel Therapeutics, Inc. - Sof daromad